Cosmos Health Inc (COSM) is not a good buy for a beginner, long-term investor at this moment. The stock is currently in a bearish trend with significant price declines in pre-market, regular market, and post-market sessions. Despite positive news about revenue growth and new contracts, the technical indicators, options data, and lack of recent trading signals suggest a weak entry point. Additionally, there is no recent congress trading data or analyst rating updates to support a strong buy decision.
The stock is in a bearish trend with moving averages indicating downward momentum (SMA_200 > SMA_20 > SMA_5). The RSI is neutral at 36.213, and the MACD histogram is positive but contracting. Key support levels are at 0.194 and 0.171, while resistance levels are at 0.231 and 0.268.

Record Q2 revenue exceeding $15 million, indicating strong growth potential.
Entry into the global beauty and personal care market with a premium skincare brand.
Long-term manufacturing agreements expected to enhance production capacity and revenues.
Significant price declines in pre-market (-13.28%), regular market (-11.92%), and post-market (-6.06%) sessions.
Bearish technical indicators and weak stock trend projections (-1.59% in the next week, -5.39% in the next month).
No detailed financial data available for analysis. However, the company reported record Q2 revenue exceeding $15 million, reflecting strong growth in the pharmaceutical wholesale market.
No recent analyst rating or price target updates available for Cosmos Health Inc.
